Links between mTOR and the immunoproteasome: Therapeutic targets for cardiac hypertrophy?

被引：2
|
作者：
Ackermann, Maegen A. [1 ]
机构：
[1] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Wexner Coll Med, Columbus, OH 43210 USA
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2015年 / 89卷
关键词：
UBIQUITIN-PROTEASOME SYSTEM; NF-KAPPA-B; MAMMALIAN TARGET; CARDIOMYOCYTE SURVIVAL; MYOCARDIAL-ISCHEMIA; PROTEIN-SYNTHESIS; DOWN-REGULATION; LIFE-SPAN; RAPAMYCIN; INHIBITION;
D O I：
10.1016/j.yjmcc.2015.09.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 115
页数：3
相关论文
共 50 条
  • [1] Emerging therapeutic targets for cardiac hypertrophy
    Winkle, Alexander J.
    Nassal, Drew M.
    Shaheen, Rebecca
    Thomas, Evelyn
    Mohta, Shivangi
    Gratz, Daniel
    Weinberg, Seth H.
    Hund, Thomas J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (01) : 29 - 40
  • [2] Cyclic nucleotide phosphodiesterases: therapeutic targets in cardiac hypertrophy and failure
    Barthou, Aurelien
    Kamel, Rima
    Leroy, Jerome
    Vandecasteele, Gregoire
    Fischmeister, Rodolphe
    M S-MEDECINE SCIENCES, 2024, 40 (6-7): : 534 - 543
  • [3] Decompensation of cardiac hypertrophy: Cellular mechanisms and novel therapeutic targets
    Diwan, Abhinav
    Dorn, Gerald W., II
    PHYSIOLOGY, 2007, 22 : 56 - 64
  • [4] Transcription Factors in Heart: Promising Therapeutic Targets in Cardiac Hypertrophy
    Kohli, Shrey
    Ahuja, Suchit
    Rani, Vibha
    CURRENT CARDIOLOGY REVIEWS, 2011, 7 (04) : 262 - 271
  • [5] Regression of pathological cardiac hypertrophy: Signaling pathways and therapeutic targets
    Hou, Jianglong
    Kang, Y. James
    PHARMACOLOGY & THERAPEUTICS, 2012, 135 (03) : 337 - 354
  • [6] TGF-β regulated miRNAs: therapeutic targets for cardiac hypertrophy
    Yang, Xiao
    Wang, Jian
    FASEB JOURNAL, 2013, 27
  • [7] Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure
    Kamel, Rima
    Leroy, Jerome
    Vandecasteele, Gregoire
    Fischmeister, Rodolphe
    NATURE REVIEWS CARDIOLOGY, 2023, 20 (02) : 90 - 108
  • [8] Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure
    Rima Kamel
    Jérôme Leroy
    Grégoire Vandecasteele
    Rodolphe Fischmeister
    Nature Reviews Cardiology, 2023, 20 : 90 - 108
  • [9] mTOR, cardiomyocytes and inflammation in cardiac hypertrophy
    Xu, Lifen
    Brink, Marijke
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2016, 1863 (07): : 1894 - 1903
  • [10] Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
    Tham, Yow Keat
    Bernardo, Bianca C.
    Ooi, Jenny Y. Y.
    Weeks, Kate L.
    McMullen, Julie R.
    ARCHIVES OF TOXICOLOGY, 2015, 89 (09) : 1401 - 1438
12345